ANGUS unveils new name as part of rebranding initiative
Photo courtesy of ANGUS

ANGUS unveils new name as part of rebranding initiative

ANGUS Chemical Company, based in Buffalo Grove, Illinois, U.S.A., has unveiled  a new name and logo as part of an extensive corporate rebranding initiative. 

The company, which has operated as ANGUS for more than 40 years, will rebrand and change its name to “Advancion.” 

The Advancion name reflects the significant transformation of the company into a leading global  producer of essential ingredients for the biotechnology, pharmaceutical, home and personal care, and  other consumer-oriented and industrial markets.  

ANGUS is a leading global manufacturer and marketer of specialty ingredients and consumables for  biotechnology, pharmaceutical, consumer and industrial applications. The company offers unique nitroalkane chemistries, including its flagship AMP™ (aminomethyl propanol)  multifunctional additives and TRIS AMINO™ (tromethamine) buffers, which are produced at fully  integrated manufacturing facilities in the United States and Germany.

“From material science to molecular biology, we are a company built on decades of precision and ingenuity. The high-quality, high-purity ingredients we develop and produce today are helping the  world’s most essential industries address the emerging challenges of tomorrow,” said David  Neuberger, president and CEO. 

“We are the same organisation, ownership, leadership and team of  dedicated employees. Our transition to the Advancion name and brand will more clearly represent who we are and what we do—a designer and producer of high-value consumables and ingredients that help enrich lives and enable our customers to advance the world.” 

ANGUS, a portfolio company of Ardian and Golden Gate Capital, is one of the world’s largest  suppliers of Life Sciences buffers and other proprietary chemistries. The company’s specialty  ingredients help improve product performance, quality, consistency, durability, stability and other  important attributes in end-use formulations. 

Through its recent acquisition of Expression Systems,  ANGUS also produces innovative cell culture media formulations, cell lines, molecular tools and reagents servicing high growth biologics segments including cell and gene therapies. 

The company’s transition to the new Advancion name and brand identity is targeted to be completed  in August 2023. Initial elements of the Advancion brand evolution include a new logo design inspired  by the multifunctionality and versatility of the company’s unique ingredients and a fresh, modern  color palette. 

Explore more on these topics